Stay updated on ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial

Sign up to get notified when there's something new on the ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:42:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T04:38:05.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T01:54:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has removed a citation regarding the safety and tolerability of eptinezumab in patients with migraine, which was previously included.
    Difference
    0.5%
    Check dated 2025-05-15T20:27:59.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:06:26.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the ALD403 migraine trial and the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    24%
    Check dated 2025-04-16T17:40:19.000Z thumbnail image

Stay in the know with updates to ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial page.